Automated insulin delivery systems in elderly patients with brittle type 2 diabetes DOI
Özge Telci Çaklılı, Ferhat Cetin,

Melike Ozkan

et al.

Diabetes Research and Clinical Practice, Journal Year: 2024, Volume and Issue: 218, P. 111913 - 111913

Published: Nov. 6, 2024

Language: Английский

Diabetes in Korean Adults: Prevalence, Management, and Comorbidities DOI Creative Commons
Sung Hoon Yu

Diabetes & Metabolism Journal, Journal Year: 2025, Volume and Issue: 49(1), P. 22 - 23

Published: Jan. 1, 2025

Language: Английский

Citations

0

Frailty, multimorbidity, and polypharmacy: Proposal of the new concept of the geriatric triangle DOI Creative Commons
Hiroyuki Umegaki

Geriatrics and gerontology international/Geriatrics & gerontology international, Journal Year: 2025, Volume and Issue: unknown

Published: April 14, 2025

As people age, the prevalence of frailty, multimorbidity, and polypharmacy increases, presenting significant challenges in geriatric medicine. These three elements are interrelated a bidirectional manner, forming what can be termed “geriatric triangle.” The complexity their interconnections means that addressing each issue isolation is insufficient for achieving an effective resolution. Thus, comprehensive understanding this triangle essential appropriate management. This review aims to illuminate relationships within offer insights into potential strategies managing these interconnected challenges. Geriatr Gerontol Int 2025; ••: ••–•• .

Language: Английский

Citations

0

In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec DOI Creative Commons

SUBHASH KUMAR WANGNOO,

Manash Baruah,

Sailesh Lodha

et al.

Diabetes Therapy, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 27, 2025

Hyperglycemia is a common and challenging condition in hospitalized patients both with without history of diabetes. Managing hyperglycemia effectively critical reducing complications, mortality, the length hospital stays. Insulin degludec (IDeg), an ultralong-acting basal insulin, has well-established efficacy safety profile terms managing outpatients; it demonstrated benefits clinical practice across various patient populations. This review aims to assess evidence on its suitability, as well safety, for different inpatient The specifically focuses outcomes such glycemic control, variability, (particularly hypoglycemia risk), dosing flexibility, ease titration, use special A comprehensive literature search was conducted using PubMed identify studies published between 2014 2024. Eligible included randomized controlled trials, real-world evidence, case series that examined IDeg management patients. reviewed consistently provides stable predictable control low variability. ultralong duration action, ability be titrated daily, flexibility make suitable noncritical care settings difficult-to-maintain rigid insulin schedules. Furthermore, risk hypoglycemia, particularly nocturnal IDeg. These attributes are beneficial diverse Practical advantages, administration specialized delivery device, further support settings. Unique pharmacokinetic pharmacodynamic properties IDeg, reduced risk, daily appropriate

Language: Английский

Citations

0

Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)—Special Interest Group in Diabetes DOI Creative Commons
Virginia Boccardi,

Gülistan Bahat,

Cafer Balcı

et al.

European Geriatric Medicine, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 27, 2025

This position paper aims to address the challenges of managing type 2 diabetes mellitus (T2DM) in frail older adults, a diverse and growing demographic with significant variability health status. The primary research questions are: How can frailty assessment be effectively integrated into care? What strategies optimize glycaemic control outcomes for adults? innovative tools technologies, including artificial intelligence (AI), improve management this population? uses 5 I's framework (Identification, Innovation, Individualization, Integration, Intelligence) integrate care, proposing such as tools, novel therapies, digital AI systems. It also examines metabolic heterogeneity, highlighting anorexic-malnourished sarcopenic-obese phenotypes. proposed highlights importance tailoring targets levels, prioritizing quality life, minimizing treatment burden. Strategies leveraging are emphasized their potential enhance personalized care. distinct needs two phenotypes outlined, specific recommendations each group. calls holistic, patient-centered approach care ensuring equity access innovations life. need fill evidence gaps, refine healthcare integration better vulnerable

Language: Английский

Citations

0

Risk factors influencing fall risk in geriatric patients with type 2 diabetes: a comprehensive analysis DOI Creative Commons
Muharrem Bayrak, Kamber Kaşalı, Merve Güner

et al.

The Aging Male, Journal Year: 2025, Volume and Issue: 28(1)

Published: March 1, 2025

Background and objectives Type 2 diabetes mellitus (T2DM) is a common chronic disease in the elderly. Comorbidities, especially neuropathy retinopathy, significantly increase fall risk this group. This study aimed to identify factors older adults with T2DM.

Language: Английский

Citations

0

Automated insulin delivery systems in elderly patients with brittle type 2 diabetes DOI
Özge Telci Çaklılı, Ferhat Cetin,

Melike Ozkan

et al.

Diabetes Research and Clinical Practice, Journal Year: 2024, Volume and Issue: 218, P. 111913 - 111913

Published: Nov. 6, 2024

Language: Английский

Citations

0